+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Latin American Defibrillators Market 2019-2025

  • PDF Icon

    Report

  • January 2020
  • Region: Latin America
  • Orion Market Research Private Limited
  • ID: 4969041
UP TO OFF until Dec 31st 2022
Latin America is expected to contribute in the defibrillator market, especially in the key regions including Brazil, Mexico and others. Brazil has considerable contribution in the market due to rise in heart diseases across the country. Obesity and overweight are the key factors responsible for heart diseases such as CVD, CDH, HF, and stroke. The government of Brazil is promoting AED and creating awareness about life-threatening diseases such as CVD, CHD and HF. Brazil is an emerging economy and has improved healthcare system with quality care and economic cost of surgeries. The healthcare spending of Brazil has improved over the years and the per capita income of Brazilians has risen above 25%. The defibrillator market is increasing in Brazil due to huge CVD, CHD and other heart patients.

CVD and diabetes are responsible for around 38% deaths in Brazil. However, fatality has decreased and life expectancy has improved to 73 from 52 years. Urbanization, adoption of innovative defibrillation devices, and improved healthcare system are expected to drive the Brazilian defibrillator market. Whereas, Mexico has made considerable advancement in healthcare systems in the Latin American region and enables to provide quality healthcare to the citizens at marginally higher prices. CVD, CHD, stroke, heart failure, atrial fibrillation and other heart diseases are the leading causes of fatalities in Mexico.

According to WHO, high blood pressure, hypertension, obesity, CVD, CHD, and stroke are more prevalent in Mexico; and harmful stress, depression, excessive consumption of alcohol, excessive smoking, hypertension, diabetes, obesity and poor diet are the major factors for heart diseases, which are also prevalent in Mexico. However, improvement in healthcare system and government programs to make citizen aware about heart diseases such as cardiac arrest is expected to curb fatalities. The Mexican government has implemented various healthcare schemes for its citizens. Development in healthcare system and adoption of defibrillation technology enabled to save many lives in Mexico as a result, life expectancy has increased in Mexico.

Research Methodology

The market study of the Latin American Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Latin American Defibrillators Market Research and Analysis by Type

2. Latin American Defibrillators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the Latin American Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Latin American Defibrillators market.
  • Insights about market determinants which are stimulating the Latin American Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Latin American Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Latin American Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Regional Analysis
6.1. Brazil
6.2. Mexico
6.3. Rest of Latin America
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Biotronik SE & Co. KG
7.3. Fukuda Denshi Co. Ltd.
7.4. General Electric Co.
7.5. HeartSine Technologies
7.6. Koninklijke Philips N.V.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. Nihon Kohden Corp.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Biotronik SE & Co. KG
  • Fukuda Denshi Co. Ltd.
  • General Electric Co.
  • HeartSine Technologies
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Nihon Kohden Corp.